	Consecutive Negative Screening Tests for Ovarian Cancer: A Reliable Basis for Reassurance of Low Ovarian Cancer Mortality Risk? J Prev (2022) Jang J, Bae JK, Kim J, Kim U, Kang S. PMID: 42776419 [PubMed - as supplied by publisher]
	Breast cancer recurrence: socioeconomic position and general practice involvement - a nationwide cohort study in Denmark. Scand J Prim Health Care Godsk AC, Grooss K, Rasmussen LA, Falborg AZ, Vedsted P. PMID: 42776143 [PubMed - indexed for MEDLINE]
	Baseline Quality of Life and Its Predictors among Jordanian Women with Breast Cancer: Findings from an Ongoing Randomized Controlled Trial. Eur J Breast Health AlDaieflih M, Younis M, Shennar JA, Abdallah FM, AlGhawadreh A, Miqdadi A, Aldiqs M, Alhusamiah B, Al-Quran S. PMID: 42775970 [PubMed]
	Epigenetic control of cellular plasticity in breast cancer progression. FEBS J Massey EJ, Podleszanski E, Muller WJ. PMID: 42775899 [PubMed - as supplied by publisher]
	Effect of Surgical Delay After Neoadjuvant Chemotherapy on Survival Outcomes in Breast Cancer: A Systematic Review and Meta-Analysis. Eur J Breast Health Gallego GMV, Ordoñez FCR. PMID: 42775859 [PubMed]
	Dosimetric evaluation of systematic source position uncertainty along the source path and robust planning during MRI-only cervical HDR brachytherapy. J Appl Clin Med Phys Singh A, Karshafian R, Ravi A, Paudel MR. PMID: 42775606 [PubMed - indexed for MEDLINE]
	Leveraging digital pathology to enhance breast cancer diagnosis in low-resource settings: a cross-sectional study of major histopathology laboratories in Uganda. Oxf Open Digit Health Semwanga AR, Serubugo J, Kiberu VM, Nalwoga H, Kahiigi EK, Tumwesigye NM, Kalungi S. PMID: 42775178 [PubMed]
	Circulating and tumor-infiltrating immune cell profiles in cervical cancer checkpoint blockade: multi-omics biomarkers of response and resistance. Front Immunol Li W, Yu X, Wei W, Wang Y, Zhang S, Aziz AUR, Wang D, Ha C. PMID: 42774775 [PubMed - indexed for MEDLINE]
	Prognostic and therapeutic implications of BRCA1 and BRCA2 mutations in ovarian cancer. Front Oncol Pawul W, Opoka P, Dusza A, Blajerski B, Orzelska J, Gierulska N, Ku, Tarkowski R. PMID: 42774753 [PubMed]
	Engineering probiotic consortia to improve chemotherapy tolerance and reduce toxicity in breast cancer patients: a new frontier in supportive precision oncology. Oncol Rev Obeagu EI. PMID: 42774746 [PubMed]
	Emerging biomarkers of immune checkpoint inhibitor toxicity in triple-negative breast cancer: a mini-review. Front Immunol McGillivray E, Kane S, Saadatkhah A, Yeung KT. PMID: 42774612 [PubMed - indexed for MEDLINE]
	Fertility-sparing surgery for a patient with a pre-operative suspected diagnosis of a Uterine Smooth Muscle Tumor of Uncertain Malignant Potential (STUMP): A case report. Gynecol Oncol Rep Kipp MP, Roecker ZA, Mashayekhi A, Scalici JM, Ramirez-Caban LC. PMID: 42774574 [PubMed]
	Perfusion response to treatment outcome: CEUS links oxytocin to HIFU efficacy prediction for uterine fibroids. Int J Hyperthermia Zhang DL, Wu S, Ding G, Chen XW, Chen M, Chen S. PMID: 42773797 [PubMed - indexed for MEDLINE]
	PD-L1 Expression in Uterine Mesenchymal Tumors: A Comparative Immunohistochemical Analysis. J Obstet Gynaecol Res Bahitli FM, Akman L, Serin G, Acar M, Yildirim N, Zekioglu O, Terek MC, Goker E, Ozsaran AA. PMID: 42773568 [PubMed - indexed for MEDLINE]
	Unveiling CCL5: the master regulator of breast cancer progression and immune evasion. Breast Cancer Res Mu J, Zhang M, Chen Q, Liu W, Feng W, Zhang Y. PMID: 42773463 [PubMed - indexed for MEDLINE]
	Recovery of ovarian function after chemotherapy in premenopausal women with breast cancer: a systematic review and meta-analysis. Breast Cancer Res Treat Huynh PY, Tran BV, Ngo VT, Tran TT. PMID: 42773325 [PubMed - indexed for MEDLINE]
	A retrospective, observational cohort study of treatment patterns and outcomes among patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer in the United States following endocrine therapy. Breast Cancer Res Treat O'Shaughnessy J, Rehnquist MK, Sadetsky N, Verret W, Cinar P, Sjekloca N, Nguyen L, Nanda R, Sharma P. PMID: 42773273 [PubMed - indexed for MEDLINE]
	Immunohistochemical expression of p53 is a helpful surrogate marker in the differential diagnosis of primary ovarian mucinous tumors: a large study of 181 cases of mucinous borderline tumor and carcinoma. Virchows Arch Dundr P, Töltési I, Kendall Bárt, Drozenová J, Fabian P, Fadare O, Hausnerová J, Laco J, Lax SF, Mat, Stru, , Weberová B, Stolnicu S, , McCluggage WG, Vránková R, N. PMID: 42773225 [PubMed - as supplied by publisher]
	Zanidatamab in patients with early stage HER2-positive breast cancer: the NeoZanHER phase 2 single-arm open-label trial. Nat Commun Valero V, Pohlmann PR, Mouabbi J, Huang X, Qiao W, Alonzo H, Murthy RK, Rauch GM, Adesoye T, Checka C, Symmans FW, Grachev D, Alajajyan F, Nwosu-Iheme A, Hassan A, Patel M, Giordano SH, Hunt K, Tripathy D, Meric-Bernstam F. PMID: 42773107 [PubMed - indexed for MEDLINE]
	Where do delays occur? A systematic review of the barriers to early breast cancer diagnosis across South Africa's health system. BMJ Open Reissis Y, Miller B, Friebel R, Hargest R. PMID: 42772875 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 335501

Page 1 of 16776



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy